D. Nochlin

发表

Causes of Death Associated with Alzheimer Disease: Variation by Level of Cognitive Impairment Before Death

W. Kukull, E. Larson, J. Bowen, 1994, Journal of the American Geriatrics Society.

Clinico‐Neuropathological Correlation of Alzheimer's Disease in a Community‐Based Case Series

Linda Teri, David Nochlin, E. Larson, 1999, Journal of the American Geriatrics Society.

Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes.

J Q Trojanowski, D A Pollen, T D Bird, 1998, The American journal of pathology.

Missense mutations in the regulatory domain of PKC gamma: a new mechanism for dominant nonepisodic cerebellar ataxia.

Zoran Brkanac, David Nochlin, C. Verlinde, 2003, American journal of human genetics.

Neuronal nuclear antigen (NeuN): a marker of neuronal maturation in the early human fetal nervous system 1 Presented at the XIII International Congress of Neuropathology, Perth, Australia, September 7–12, 1997. 1

Harvey B Sarnat, David Nochlin, D. Born, 1998, Brain and Development.

APOE and other loci affect age‐at‐onset in Alzheimer's disease families with PS2 mutation

G. Schellenberg, E. Wijsman, E. W. Daw, 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Frequency of tau gene mutations in familial and sporadic cases of non-Alzheimer dementia.

G. Schellenberg, J. Trojanowski, D. Galasko, 2001, Archives of neurology.

Constitutive Cdc25B tyrosine phosphatase activity in adult brain neurons with M phase-type alterations in Alzheimer’s disease

I. Vincent, D. Nochlin, K. Hudson, 2001, Neuroscience.

Constitutive Wee1 activity in adult brain neurons with M phase-type alterations in Alzheimer neurodegeneration.

I. Vincent, Lee-way Jin, D. Nochlin, 2001, Journal of Alzheimer's disease : JAD.

Neuropathological findings in patients with clinical diagnoses of probable Alzheimer's disease.

S. M. Sumi, T. Bird, E. Peskind, 1990, The American journal of psychiatry.

Cationic dyes reveal proteoglycans structurally integrated within the characteristic lesions of Alzheimer's disease

D. Nochlin, T. Wight, S. Lara, 2004, Acta Neuropathologica.

Peripheral distribution of dermatan sulfate proteoglycans (decorin) in amyloid-containing plaques and their presence in neurofibrillary tangles of Alzheimer's disease.

H. Kresse, D. Nochlin, T. Wight, 1992, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Morphology and distribution of cytoplasmic inclusions in adrenoleukodystrophy

D. Nochlin, E. Myer, N. Ghatak, 1981, Journal of the Neurological Sciences.

A proposed classification of familial Alzheimer’s disease based on analysis of 32 multigeneration pedigrees

S. M. Sumi, G. Schellenberg, T. Bird, 1990 .

Correction: A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L) (Brain (1999) 122, 4 (741-756))

G. Schellenberg, J. Kaye, H. Payami, 1999 .

Myoclonus, Seizures, and Paratonia in Alzheimer Disease

S. M. Sumi, T. Bird, E. Peskind, 1990, Alzheimer disease and associated disorders.

Hyperphosphorylation of RNA Polymerase II and Reduced Neuronal RNA Levels Precede Neurofibrillary Tangles in Alzheimer Disease

I. Vincent, J. Leverenz, D. Bregman, 2001, Journal of neuropathology and experimental neurology.

Mitotic activation: a convergent mechanism for a cohort of neurodegenerative diseases

I. Vincent, D. Nochlin, J. Husseman, 2000, Neurobiology of Aging.

Phenotypic Variability of Gerstmann-Straussler-Scheinker Disease is Associated with Prion Protein Heterogeneity

D. Dickson, B. Ghetti, S. Kish, 1998, Journal of neuropathology and experimental neurology.

Familial dementia with PrP‐positive amyloid plaques

S. M. Sumi, T. Bird, K. Beyreuther, 1989, Neurology.

Amyloid (Aβ) deposition in chromosome 1–linked Alzheimer's disease: The volga german families

S. M. Sumi, D. Mann, T. Iwatsubo, 1997, Annals of neurology.

Amyloid beta protein (Abeta) deposition in chromosome 14-linked Alzheimer's disease: predominance of Abeta42(43).

S. M. Sumi, J. Hardy, P. Lantos, 1996, Annals of neurology.

The Presence ofHeparan Sulfate Proteoglycans in the Neuritic Plaques and Congophilic Angiopathy in Alzheimer ' s Disease

Masato Kato, D. Nochlin, T. Wight, 2007 .

Transgenic Animal Models for Alzheimer's Disease a

S. M. Sumi, S. Deeb, D. Kunkel, 1993, Annals of the New York Academy of Sciences.

High levels of circulating β-amyloid peptide do not cause cerebral β-amyloidosis in transgenic mice

J. Wegiel, H. Wiśniewski, S. Younkin, 1996 .

Comparison of postmortem magnetic resonance imaging and neuropathologic findings in the cerebral white matter.

Scott T. Grafton, S. M. Sumi, S T Grafton, 1991, Archives of neurology.

The Mean Aβ Load in the Hippocampus Correlates with Duration and Severity of Dementia in Subgroups of Alzheimer Disease

S. M. Sumi, Yongmin Kim, D. Nochlin, 1997, Journal of Neuropathology and Experimental Neurology.

Familial prion disease with alzheimer disease‐like tau pathology and clinical phenotype

G. Schellenberg, T. Montine, B. Ghetti, 2011, Annals of neurology.

Prion proteins with different conformations accumulate in Gerstmann-Sträussler-Scheinker disease caused by A117V and F198S mutations.

B. Ghetti, C. DeCarli, M. Ball, 2001, The American journal of pathology.

CHARACTERISTICS OF FAMILIAL ALZHEIMER'S DISEASE IN NINE KINDREDS OF VOLGA GERMAN ANCESTRY

S. M. Sumi, G. Schellenberg, E. Wijsman, 1989, Progress in clinical and biological research.

Rosai-Dorfman disease manifesting as intracranial and intraorbital lesion

J. Landolfi, D. Nochlin, Archana Hinduja, 2009, Journal of Neuro-Oncology.

Fenestrated blood vessels in human skeletal muscle

D. Nochlin, N. Ghatak, NITYA R. Ghatak, 1979, Acta Neuropathologica.

A simple method of rapid freezing adequately preserves brain tissue for immunocytochemistry, light and electron microscopic examination

S. M. Sumi, T. Norwood, D. Nochlin, 2004, Acta Neuropathologica.

Corpora Amylacea in Aging and Alzheimer’s Brain: Immunolocalization of Chondroitin Sulfate and Heparan Sulfate Proteoglycans

M. Raskind, D. Nochlin, T. Wight, 1988 .

IMMUNOLOCALIZATION OF HEPARAN SULFATE PROTEOSLYCANS TO “PRIMITIVE PLAQUES” AND MULTI‐CORE PRION POSITIVE PLAQUES IN FAMILIAL DEMENTIA

S. M. Sumi, T. Bird, D. Nochlin, 1988 .

The impact of different presenilin 1 andpresenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer's disease brain: evidence for other phenotype-modifying factors.

B. Hyman, P. Lantos, N. Cairns, 1999, Brain : a journal of neurology.

Evidence for a novel late-onset Alzheimer disease locus on chromosome 19p13.2.

Ellen M Wijsman, Erin M. Conlon, David Nochlin, 2004, American journal of human genetics.

Familial Alzheimer's disease: Site of mutation influences clinical phenotype

D. Pollen, P. S. St George-Hyslop, D. Drachman, 2000, Annals of Neurology.

Presenilin‐1 protein expression in familial and sporadic Alzheimer's disease

A. Levey, C. Heilman, S. Mirra, 1997, Annals of neurology.

Antibodies to presenilin proteins detect neurofibrillary tangles in Alzheimer's disease.

L. Forno, T. Bird, W. Ellis, 1996, The American journal of pathology.

Amyloid β protein (Aβ) deposition in chromosome 14–linked Alzheimer's disease: Predominance of Aβ42(43)

S. M. Sumi, P. Lantos, M. Rossor, 1996 .

Absence of linkage of chromosome 21q21 markers to familial Alzheimer's disease.

S. M. Sumi, G. Schellenberg, E. Wijsman, 1988, Science.

Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements.

G. Schellenberg, V. Lee, T. Bird, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Multiple vascular malformation in the ‘blue rubber bleb naevus’ syndrome: a case with aneurysm of vein of Galen and vascular lesions suggesting a link to the Weber–Osler–Rendu syndrome

D. Nochlin, W. Rosenblum, N. Ghatak, 1978, Histopathology.

The number of trait loci in late-onset Alzheimer disease.

E M Wijsman, T D Bird, G. Schellenberg, 2000, American journal of human genetics.

Management of Malignant Meningiomas

J. Landolfi, D. Nochlin, T. Steineke, 2012 .

Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain.

R. Kalaria, D. Nochlin, K. Kimata, 1994, The American journal of pathology.

The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease.

D. Nochlin, S. Suzuki, T. Wight, 1988, The American journal of pathology.

The cell cycle Cdc25A tyrosine phosphatase is activated in degenerating postmitotic neurons in Alzheimer's disease.

I. Vincent, D. Nochlin, A. Tomashevski, 2000, The American journal of pathology.

Decreased levels of soluble amyloid β‐protein precursor are associated with Alzheimer's disease in concordant and discordant monozygous twin pairs

M. Pandian, S. Wagner, M. Farlow, 1994, Annals of neurology.

Transgenic Mice Over-Expressing the C-99 Fragment of βPP with an α-Secretase Site Mutation Develop a Myopathy Similar to Human Inclusion Body Myositis

George M. Martin, David Nochlin, G. Martin, 1998 .

Identification and Immunolocalization of a New Class of Proteoglycan (Keratan Sulfate) to the Neuritic Plaques of Alzheimer's Disease

D. Nochlin, A. Snow, S. Carlson, 1996, Experimental Neurology.

A new dominant spinocerebellar ataxia linked to chromosome 19q13.4-qter.

T. Bird, D. Nochlin, W. Raskind, 2002, Archives of neurology.

Phenotypic heterogeneity in familial alzheimer's disease: A study of 24 kindreds

S. M. Sumi, T D Bird, G. Schellenberg, 1989, Annals of neurology.

Role of choroid plexus epithelium in the removal of valproic acid from the central nervous system

A. Artru, D. Shen, K. Adkison, 1995, Epilepsy Research.

Glial outgrowth along spinal nerve roots in amyotrophic lateral sclerosis

D. Nochlin, N. Ghatak, David Nochlin, 1982, Annals of neurology.

Immunolocalization of heparan sulfate proteoglycans to the prion protein amyloid plaques of Gerstmann-Straussler syndrome, Creutzfeldt-Jakob disease and scrapie.

S. Prusiner, S. DeArmond, D. Nochlin, 1990, Laboratory investigation; a journal of technical methods and pathology.

The Arctic AβPP mutation leads to Alzheimer’s disease pathology with highly variable topographic deposition of differentially truncated Aβ

G. Schellenberg, T. Bayer, M. Lalowski, 2013, Acta neuropathologica communications.

Clinical and neuropathological features of the arctic APP gene mutation causing early-onset Alzheimer disease.

G. Schellenberg, L. Wahlund, N. Bogdanovic, 2008, Archives of neurology.

An important role of heparan sulfate proteoglycan (perlecan) in a model system for the deposition and persistence of fibrillar aβ-amyloid in rat brain

P. Fraser, D. Nochlin, D. Morgan, 1994, Neuron.

AMY plaques in familial AD

J. Trojanowski, V. Lee, T. Bird, 2000, Neurology.

The Arctic AβPP mutation leads to Alzheimer’s disease pathology with highly variable topographic deposition of differentially truncated Aβ

G. Schellenberg, T. Bayer, M. Lalowski, 2013, Acta Neuropathologica Communications.

Comparison of the severity of neuropathologic changes in familial and sporadic Alzheimer's disease.

S. M. Sumi, G. van Belle, T. Bird, 1993, Alzheimer disease and associated disorders.

Phenotype-genotype analysis of dystrophinopathy caused by duplication mutation in Dystrophin gene in an African patient.

R. Grewal, D. Nochlin, L. Sharer, 2011, African health sciences.

Effect of Vascular Lesions on Cognition in Alzheimer's Disease: A Community‐Based Study

E. Larson, D. Tsuang, J. Bowen, 2004, Journal of the American Geriatrics Society.

Clinicopathological concordance and discordance in three monozygotic twin pairs with familial Alzheimer’s disease

G. Schellenberg, T. Bird, J. Leverenz, 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

Alzheimer's disease in three monozygotic twin pairs with familial Clinicopathological concordance and discordance

J. Leverenz, W. Yuan, D. Nochlin, 2007 .

Familial presenile dementia with psychosis associated with cortical neurofibrillary tangles and degeneration of the amygdala

S. M. Sumi, T. Bird, M. Raskind, 1992, Neurology.

Clinical and neuropathological characteristics of hippocampal sclerosis: a community-based study.

W. Kukull, S. Edland, E. Larson, 2002, Archives of neurology.

A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L)

G. Schellenberg, J. Kaye, H. Payami, 1999, Brain : a journal of neurology.

Lewy body pathology in familial Alzheimer disease: evidence for disease- and mutation-specific pathologic phenotype.

G. Schellenberg, T. Montine, T. Bird, 2006, Archives of neurology.

Chromosome 17 and hereditary dementia

S. M. Sumi, G. Schellenberg, E. Wijsman, 1997, Neurology.

Neuropathological heterogeneity in Alzheimer’s disease: A study of 80 cases using principal components analysis

T D Bird, R A Armstrong, T. Bird, 2000, Neuropathology : official journal of the Japanese Society of Neuropathology.

Phenotype of chromosome 14–linked familial Alzheimer's disease in a large kindred

S. M. Sumi, T. Bird, E. Nemens, 1994, Annals of neurology.

Failure to detect Chlamydia pneumoniae in brain tissues of Alzheimer’s disease

D. Nochlin, C. Shaw, L. Campbell, 1999, Neurology.

Transgenic mice over-expressing the C-99 fragment of betaPP with an alpha-secretase site mutation develop a myopathy similar to human inclusion body myositis.

G. Martin, C. Ogburn, W. Ladiges, 1998, The American journal of pathology.

Clinical-neuropathologic findings in multi-infarct dementia

S. M. Sumi, S. Mirra, A. Heyman, 1997, Neurology.

A CHARACTERISTIC BINDING AFFINITY BETWEEN HEPARAN SULFATE PROTEOGLYCANS AND THE A4 AMYLOID PROTEIN OF ALZHEIMERʼS DISEASE: 154

D. Selkoe, M. Podlisny, D. Nochlin, 1989 .

Kikuchi-Fujimoto Disease Associated with Myasthenia Gravis: A Case Report

R. Grewal, D. Nochlin, O. Onasanya, 2010, Case reports in medicine.

Neuropathologic diagnostic outcomes from a cohort of outpatients with suspected dementia.

S. M. Sumi, E. Larson, D. Nochlin, 1996, The journals of gerontology. Series A, Biological sciences and medical sciences.

The utility of apolipoprotein E genotyping in the diagnosis of Alzheimer disease in a community-based case series.

G. Schellenberg, M. Gearing, S. Mirra, 1999, Archives of neurology.

Amyloid angiopathy in a volga german family with Alzheimer's disease and a presenilin‐2 mutation (N141I)

S. M. Sumi, M. Ball, T. Bird, 1998, Annals of neurology.

Evaluation of Selection Bias in an Incident-Based Dementia Autopsy Case Series

S. Edland, M. Thompson, E. Larson, 2005, Alzheimer disease and associated disorders.

Detection and Quantitation of Perlecan mRNA Levels in Alzheimer's Disease and Normal Aged Hippocampus by Competitive Reverse Transcription‐Polymerase Chain Reaction

D. Erezyilmaz, D. Nochlin, C. Murry, 1996, Journal of neurochemistry.

Neurofibrillary pathology in progressive supranuclear palsy

M. Hadfield, D. Nochlin, N. R. Ghatak, 2004, Acta Neuropathologica.

De novo formation of large arteriovenous shunting and a vascular nidus mimicking an arteriovenous malformation within an anaplastic oligodendroglioma: treatment with embolization and resection.

J. Brisman, D. Nochlin, J. McKinney, 2008, Journal of neurosurgery.

Brain Expression of Presenilins in Sporadic and Early-onset, Familial Alzheimer’s Disease

P. Fraser, T. Bird, C. Hulette, 2000, Molecular medicine.

High levels of circulating beta-amyloid peptide do not cause cerebral beta-amyloidosis in transgenic mice.

J. Wegiel, H. Wiśniewski, S. Younkin, 1996, American Journal of Pathology.

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

S. M. Sumi, U. Slager, B. Hyman, 1991, Neurology.

Identification in immunolocalization of a new class of proteoglycan (keratan sulfate) to the neuritic plaques of Alzheimer's disease.

D. Nochlin, A. Snow, S. Carlson, 1996, Experimental neurology.

Kikuchi-Fujimoto Disease Associated with Myasthenia Gravis: A Case Report

R. Grewal, D. Nochlin, O. Onasanya, 2010, Case reports in medicine.

With Clinical Diagnoses of Probable Alzheimer's Disease

T. Bird, E. Peskind, M. Raskind, 1990 .

Familial prion disease with alzheimer disease‐like tau pathology and clinical phenotype

G. Schellenberg, T. Montine, B. Ghetti, 2011, Annals of neurology.

Clinicopathologic correlations of soluble amyloid beta-protein precursor in cerebrospinal fluid in patients with Alzheimer disease and controls.

G. Schellenberg, M. Pandian, D. Nochlin, 1997, Alzheimer disease and associated disorders.

Counting plaques and tangles in Alzheimer's disease: Concordance of technicians and pathologists

G. Belle, E. Larson, K. Gibson, 1997, Journal of the Neurological Sciences.